Sayeski PP - Search Results

1

Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.

He K, Wang X, Jiang J, Guan R, Bernstein KE, Sayeski PP, Frank SJ. He K, et al. Among authors: sayeski pp. Mol Endocrinol. 2003 Nov;17(11):2211-27. doi: 10.1210/me.2003-0256. Epub 2003 Aug 14. Mol Endocrinol. 2003. PMID: 12920237

2

A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.

Jiang J, Wang X, He K, Li X, Chen C, Sayeski PP, Waters MJ, Frank SJ. Jiang J, et al. Among authors: sayeski pp. Mol Endocrinol. 2004 Dec;18(12):2981-96. doi: 10.1210/me.2004-0102. Epub 2004 Sep 2. Mol Endocrinol. 2004. PMID: 15345746

3

Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression.

Wallace TA, VonDerLinden D, He K, Frank SJ, Sayeski PP. Wallace TA, et al. Among authors: sayeski pp. Am J Physiol Cell Physiol. 2004 Oct;287(4):C981-91. doi: 10.1152/ajpcell.00085.2004. Epub 2004 Jun 9. Am J Physiol Cell Physiol. 2004. PMID: 15189810 Free article.

4

Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor.

Ali MS, Sayeski PP, Bernstein KE. Ali MS, et al. Among authors: sayeski pp. J Biol Chem. 2000 May 19;275(20):15586-93. doi: 10.1074/jbc.M908931199. J Biol Chem. 2000. PMID: 10748109 Free article.

5

Janus kinase 2 (Jak2) must be catalytically active to associate with the AT1 receptor in response to angiotensin II.

Ali MS, Sayeski PP, Safavi A, Lyles M, Bernstein KE. Ali MS, et al. Among authors: sayeski pp. Biochem Biophys Res Commun. 1998 Aug 28;249(3):672-7. doi: 10.1006/bbrc.1998.9054. Biochem Biophys Res Commun. 1998. PMID: 9731195

6

Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity.

VonDerLinden D, Ma X, Sandberg EM, Gernert K, Bernstein KE, Sayeski PP. VonDerLinden D, et al. Among authors: sayeski pp. Mol Cell Biochem. 2002 Dec;241(1-2):87-94. doi: 10.1023/a:1020829617779. Mol Cell Biochem. 2002. PMID: 12482029

7

Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation].

Sandberg EM, Ma X, He K, Frank SJ, Ostrov DA, Sayeski PP. Sandberg EM, et al. Among authors: sayeski pp. J Med Chem. 2005 Apr 7;48(7):2526-33. doi: 10.1021/jm049470k. J Med Chem. 2005. PMID: 15801842

8

The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src.

Sayeski PP, Ali MS, Hawks K, Frank SJ, Bernstein KE. Sayeski PP, et al. Circ Res. 1999 Jun 11;84(11):1332-8. doi: 10.1161/01.res.84.11.1332. Circ Res. 1999. PMID: 10364571

9

A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn.

Sayeski PP, Ali MS, Safavi A, Lyles M, Kim SO, Frank SJ, Bernstein KE. Sayeski PP, et al. J Biol Chem. 1999 Nov 12;274(46):33131-42. doi: 10.1074/jbc.274.46.33131. J Biol Chem. 1999. PMID: 10551884 Free article.

10

The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR.

Sayeski PP, Ali MS, Frank SJ, Bernstein KE. Sayeski PP, et al. J Biol Chem. 2001 Mar 30;276(13):10556-63. doi: 10.1074/jbc.M008856200. Epub 2001 Jan 4. J Biol Chem. 2001. PMID: 11152457 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters